SA PRO
Free Account
Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
10 analysts·Moderate coverage
100%
Rating Distribution
Strong Buy
00%
Buy
10100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 29, 2025Mizuho Securities
Amylyx price target raised to $16 from $12 at Mizuho
Target:$16.00
+14.8%from $13.94
Oct 16, 2025Robert W. Baird
Amylyx price target raised to $19 from $10 at Baird
Target:$19.00
+20.3%from $15.79
Sep 15, 2025Guggenheim
Amylyx price target raised to $25 from $17 at Guggenheim
Target:$25.00
+111.0%from $11.85
Jun 24, 2025Guggenheim
Amylyx initiated with a Buy at Guggenheim
Target:$17.00
+165.2%from $6.41
May 6, 2025Leerink Partners
Leerink upgrades Amylyx on avexitide growth opportunity
Target:$10.00
+115.1%from $4.65
Nov 18, 2024Robert W. Baird
Baird Upgrades Amylyx Pharmaceuticals inc. (AMLX) to Outperform
Target:$11.00
+131.1%from $4.76
Oct 23, 2024Bank of America Securities
BofA Securities Upgrades Amylyx Pharmaceuticals inc. (AMLX) to Buy
Target:$10.00
+120.8%from $4.53
Oct 18, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)
Target:$8.00
+104.1%from $3.92
Oct 18, 2024Leerink Partners
Leerink Partners Reiterates Market Perform Rating on Amylyx Pharmaceuticals inc. (AMLX)
Target:$4.00
+2.0%from $3.92
May 14, 2024Mizuho Securities
Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3 at Mizuho
Target:$3.00
+64.8%from $1.82
Apr 11, 2024Robert W. Baird
Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3 at Baird on latest AMX0035 data
Target:$3.00
+22.0%from $2.46
Apr 4, 2024Deutsche Bank
Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $4 at Deutsche Bank
Target:$4.00
+53.0%from $2.62
Mar 17, 2024Mizuho Securities
Mizuho Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral
Target:$4.00
+23.5%from $3.24

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance